This page contains a Flash digital edition of a book.
the development of serum (or blood) markers, which may be divided into direct or indirect tests, either singly, or combined as serum panel markers, and the application of imaging-based technologies, such as ultrasound and magnetic resonance techniques.


SERUM MARKERS Serum may be obtained at routine venepuncture, making it quick and acceptable to most patients. Sampling variability is negated, although site- specificity to hepatic processes may be questioned. Serum markers may broadly be divided into indirect and direct markers of hepatic fibrosis. Indirect markers are those where the indices measured correlate with fibrosis stage, but are not integral to the pathogenesis of disease. Such markers include so-called liver function tests, such as aspartate and alanine aminotransferases (AST and ALT), and composite or panel markers, such as the AST-to-platelet ratio index (APRI) and the Fibrotest/Actitest markers. On the other hand, direct markers are those measuring intermediates or metabolites of fibrogenesis, such as hyaluronic acid and panel markers such as the Enhanced Liver Fibrosis (ELF) test, consisting of metalloproteinase-1 (TIMP-1), procollagenase 3 and hyaluronic acid. The performance of a number of these tests for the detection of cirrhosis is displayed in Table 1.


dpe rm Lm e l 05 atd fo i t a. 20.


Figure 1: Transient elastography. A specialist nurse places the probe perpendicular to the surface of the liver. A low frequency shear wave is generated along the same axis as the ultrasound transducer. The velocity of the shear wave through the liver is measured by a high frequency ultrasound signal and the output displayed as stiffness, in kPa, alongside a two- dimensional “elastogram”. The output is the median of 10 measurements, with a success rate of >66% and an interquartile range of measurements <1/3 of the median considered satisfactory.


IMAGING-BASED MARKERS Investigations based on imaging modalities, including ultrasound and magnetic resonance (MR), are liver-specific and often provide hepatic structural information. Although a number of structural changes are associated with cirrhosis and portal hypertension, these signs alone are neither sensitive nor specific enough to stage chronic liver disease. A number of specialized applications have, however, shown promise and imaging


 Figure 2: Hepatic vascular transit times (HVTT). Time intensity curves from the hepatic vein are plotted in a normal patient and a patient with cirrhosis, showing earlier arrival of contrast in the cirrhotic liver. A 0.5


0.4 0.3 0.2 0.2 -20 0 0.5 0.4 0.3 0.2 0.2 -20 0 -10 0 58 www.lifesciencesmagazines.com 10 20 30 Time (s) 40 50 60 70 80


Cirrhosis (early HVTT) injection


-10 0 10 20 30 Time (s) 40 50 60 70 80


Normal (late HVTT) injection


techniques have the added benefit of providing real-time information to the operator and patient.


TRANSIENT ELASTOGRAPHY Transient elastography is an ultrasound elastography technique that measures the propagation of a low-frequency shear wave through the liver (see figure 1). Its velocity is dependent on the ‘stiffness’ of the liver and this reflects the degree of fibrosis. The technique currently requires use of dedicated equipment marketed as FibroScan®


and its performance has been


scrutinised in a large number of studies over the last five years. However, while transient elastography performs well for the assessment of cirrhosis, with sensitivity and specificity quoted between 77% and 100%, there has been less clear separation of stages of precirrhotic disease. Cut-off values between histological stages vary substantially between studies, patient groups and aetiology of disease. More recently, liver stiffness has been shown to increase in flares of viral hepatitis and in acute hepatitis, to levels seen in cirrhosis, but in the absence of significant fibrosis. Further studies have demonstrated compelling correlation between liver stiffness and portal pressure, while cardiac failure, infiltrative conditions and even hepatic steatosis may affect stiffness values. 


Amplitude


Amplitude


Image © Prof. Simon Taylor Robinson


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132  |  Page 133  |  Page 134  |  Page 135  |  Page 136  |  Page 137  |  Page 138  |  Page 139  |  Page 140  |  Page 141  |  Page 142  |  Page 143  |  Page 144  |  Page 145  |  Page 146  |  Page 147  |  Page 148  |  Page 149  |  Page 150  |  Page 151  |  Page 152  |  Page 153  |  Page 154  |  Page 155  |  Page 156  |  Page 157  |  Page 158  |  Page 159  |  Page 160  |  Page 161  |  Page 162  |  Page 163  |  Page 164  |  Page 165  |  Page 166  |  Page 167  |  Page 168  |  Page 169  |  Page 170  |  Page 171  |  Page 172  |  Page 173  |  Page 174  |  Page 175  |  Page 176  |  Page 177  |  Page 178  |  Page 179  |  Page 180  |  Page 181  |  Page 182  |  Page 183  |  Page 184  |  Page 185  |  Page 186  |  Page 187  |  Page 188  |  Page 189  |  Page 190  |  Page 191  |  Page 192  |  Page 193  |  Page 194  |  Page 195  |  Page 196